Results and discussion
To identify new members of the TNF cytokine family, we searched an expressed sequence tag (EST) database for sequences that have similarity to TNF. Using a set of overlapping ESTs that showed homology to TNF, we isolated a full-length cDNA from human fetal kidney that encoded an as yet undescribed member of the TNF family; we subsequently named this protein Apo3L. The cDNA predicts a 249 amino-acid polypeptide ( Figure 1a ) with a calculated molecular weight of 27 kDa. Apo3L has no apparent signal sequence at the amino terminus, but contains a hydrophobic region between amino-acid residues 20 and 46, indicating a type II transmembrane protein topology. The predicted carboxy-terminal extracellular domain (ECD) shows the highest protein sequence identity (20-23%) to TNF, CD40 ligand, lymphotoxin β and Apo2 ligand (Apo2L).
We investigated the chromosomal location of the human Apo3L gene by radiation hybrid analysis (data not shown). Apo3L showed physical linkage to Stanford Human Genome Center marker SHGC-31370 (LOD = 6.8), which maps to chromosome 17p13. Notably, the p53 tumor-suppressor gene is located in the same chromosomal region [11] . Apo3L is the first member of the TNF gene family that maps to chromosome 17.
We analyzed the mRNA expression of Apo3L in comparison to TNF by northern blot hybridization (Figure 1b-d) . We identified a 2 kb Apo3L transcript in essentially all the fetal and adult tissues examined. In contrast, TNF mRNA, expressed as a 2.2 kb transcript, appeared only in peripheral blood leukocytes (PBLs) and spleen. Apo3L and TNF transcripts were also differentially expressed in several human tumor cell lines.
To investigate the signaling pathways engaged by Apo3L, we generated a polyhistidine-tagged form of the Apo3L ECD (amino acids 47-249) in Escherichia coli [12] . Purified soluble Apo3L induced apoptosis in human MCF-7 breast carcinoma cells or in HeLa S3 cervical carcinoma cells within a period of 14 hours ( Figure 2a,b) ; apoptosis was evident by morphological changes, chromatin condensation and internucleosomal DNA fragmentation. Apo3L-induced apoptosis was augmented by the translation inhibitor cycloheximide (Figure 2c ), indicating that the apoptosis was independent of de novo protein synthesis. Addition of the peptide-based caspase inhibitors DEVDfmk and zVAD-fmk (Figure 2a,b) , or transfection with the virus-derived caspase inhibitors CrmA or p35 (Figure 2d ), blocked induction of apoptosis by Apo3L, indicating a requirement for caspase activity. In addition, transfection with a dominant-negative mutant [13] of the deathdomain-containing adaptor FADD/MORT1, which is required for apoptosis induction by TNF through TNF receptor 1 (TNFR1) and by CD95 ligand through CD95 [3] , prevented apoptosis induction by Apo3L. Hence, Apo3L activates caspases through FADD or a closely related protein.
Next, we investigated whether Apo3L activates the transcription factor NF-κB. Apo3L induced a marked increase in NF-κB-specific DNA-binding activity in human embryonic kidney 293 cells, as did TNF (Figure 3a) . Similar results were obtained in MCF-7 and in HeLa S3 cells (data not shown). Transfection with dominant-negative mutants of cytoplasmic factors involved in TNF-induced, TNFR1-mediated activation of NF-κB [10] , namely, TRADD (TNFR-associated death-domain protein) [14, 15] , RIP (receptor-interacting protein) [16, 17] , TRAF2 (TNFRassociated factor 2) [18] , or NIK (NF-κB-inducing kinase) [19, 20] , inhibited NF-κB activation by Apo3L or by TNF (Figure 3b ). Thus, Apo3L seems to use the same cytoplasmic elements that TNF employs to signal NF-κB activation. Transfection of MCF-7 cells with dominant-negative NIK caused marked sensitization to Apo3L-induced apoptosis (data not shown), suggesting that NF-κB activation by Apo3L counteracts cytotoxicity as is the case for NF-κB activation by TNF [3, 10] . Because Apo3L engaged signaling pathways that were shown previously to be activated by overexpression of Apo3 [4] [5] [6] [7] [8] , we tested whether Apo3L binds to Apo3. We generated a soluble, FLAG-epitope-tagged protein based on the ECD of Apo3 (FLAG-Apo3). We then examined the ability of histidine-tagged Apo3L to associate with FLAG-Apo3 in a co-immunoprecipitation assay ( Figure 4a) ; for comparison, we tested histidine-tagged Apo2L [12] and a FLAGepitope-tagged ECD of its receptor, death receptor 5 (DR5) [21] . Apo3L bound to Apo3, but not to DR5, whereas Apo2L bound to DR5, but not to Apo3, indicating specific complex formation between Apo3L and Apo3. Apo3L did not bind to soluble Fc fusion proteins based on the ECDs of other TNFR family members that regulate cell death, namely, TNFR1, TNFR2, CD95 or DR4 (data not shown). Preincubation of ligand with FLAG-Apo3, followed by immunodepletion of complexes with anti-FLAG antibody inhibited apoptosis induction by Apo3L, but not by Apo2L (Figure 4b ). In addition, transfection of 293 cells, which are relatively resistant to Apo3L-induced apoptosis, with low levels of full-length Apo3 cDNA caused marked sensitization to Apo3L, but not to TNF (Figure 4c ). Thus, Apo3L interacts with Apo3.
We have identified a ligand that regulates apoptosis and NF-κB activation through Apo3, similar to the way that TNF regulates these cellular responses through TNFR1. A molecule with the same sequence as Apo3L has recently been described [22] . Our results do not rule out the potential existence of other ligand interactions for Apo3 or other receptor interactions for Apo3L. The Apo3L mRNA is expressed in a wide variety of tissues, in contrast to TNF, the expression of which is much more restricted. Conversely, the tissue distribution of TNFR1 is broad [1] , whereas Apo3 expression appears restricted mainly to lymphocyte-rich tissues such as PBLs and spleen [4] [5] [6] [7] [8] .
Hence, it will be important to investigate the role of Apo3L-Apo3 interactions in immune system development and function, for example by gene 'knockouts'. Whereas
Brief Communication 527 Apo3 mRNA levels increased upon T-cell activation [7, 8] , Apo3L levels did not (data not shown). Thus, cellular sensitivity to the cytotoxic action of Apo3L might be regulated in part at the level of Apo3 expression. Additional regulatory mechanisms might involve secretion of a soluble Apo3 ECD through alternative mRNA splicing [4] [5] [6] [7] [8] , NF-κB activation, and protection by anti-apoptotic factors such as FLICE-inhibitory protein [23] . Our results indicate that Apo3L has overlapping signaling functions with TNF, but differs from TNF in its sites of production, as well as perhaps in its targets of action.
Materials and methods

Isolation of the Apo3L cDNA
We searched the LifeSeq EST DNA database (Incyte Pharmaceuticals) for sequences that show homology to the ECD of TNF family members.
We identified a set of overlapping ESTs related to TNF; PCR primers based on the region of EST consensus were used to screen a number of human cDNA libraries, of which human fetal kidney was positive for a PCR product of the expected size. This library was screened by hybridization to a 60 bp DNA probe based on the ESTs. One positive clone (DNA30879) was isolated and sequenced in entirety.
Generation of soluble Apo3L
The DNA sequence encoding the ECD of Apo3L (amino acids 47-249) was amplified by PCR and cloned into the E. coli expression plasmid pET-19B (Novagen), using NdeI and XhoI restriction sites. The Apo3L sequence was inserted in-frame and downstream of an initiating methionine, followed by 10 histidine residues, and an enterokinase cleavage site present in the vector. The protein was expressed in E. coli, extracted by microfluidization in the presence of protease inhibitors, and purified by affinity chromatography on nickel-Sepharose, essentially as described [12] . Gel analysis showed that the purified protein was capable of forming homotrimers (data not shown).
Analysis of apoptosis
Apoptosis was assessed morphologically by light microscopy, and by nuclear staining with Hoechst 33342 dye (10 µg/ml) and fluorescence microscopy. For each data point, depicted as mean ± s.e.m., live and apoptotic cells were scored in three random fields, each containing 100-200 cells. Internucleosomal DNA fragmentation was analyzed by extracting DNA from cells and 32 P-labelling the 3′ ends with terminal transferase using an Apoptotic DNA Laddering kit (Trevigen). Samples were separated by electrophoresis on 1.5% agarose gels as described [12] .
Supplementary material
A figure showing a sequence alignment of Apo3L with related proteins and additional methodological detail are available with this paper on the internet.
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Materials and methods
Genomic mapping
The chromosomal location of the human Apo3L gene was determined by PCR analysis of a panel of 83 human-mouse cell radiation hybrids (Research Genetics) with primers based on the coding region of the Apo3L cDNA. The linkages were assigned using the database of the Stanford Human Genome Center (http://www-shgc.stanford.edu/ Mapping/rh/search.html). Linkage to p53 (Whitehead Institute marker WI-9178) and to human chromosome 17p13 was established by using the NCBI Entrez browser (http://www.ncbi.nlm.nih.gov/htbinpost/ Entrez/query?db=c&form=4&field=ORGN&term=Homo+sapiens).
Analysis of mRNA expression
Expression of Apo3L mRNA in human tissues was examined by northern blot analysis. Human fetal and adult RNA blots and a human cancer cell line RNA blot (Clontech) were hybridized to a 32 P-labeled DNA probe based on the ECD of Apo3L. The probe was generated by PCR with the primers: 5′-CGACGACAAGCATATGCGGGCATCGCTGTC-CGCCCAGGAG-3′ and 5′-CAGCCGGATCCTCGAGTCAGTGAAC-CTGGAAGAGTCCG-3′.
Analysis of NF-κB activation
Cells were harvested after treatment, nuclear extracts were prepared, and 1 µg nuclear protein was reacted with a 32 P-labeled NF-κB-specific oligonucleotide probe (5′-ATCAGGGACTTTCCGCTGGGGA-CTTTCCG-3′). DNA binding was analyzed by electrophoretic mobility shift assay, as described [4] . 
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